[Electrophoretic studies of serum protein fractions in horses with laminitis].

The study investigates the changes in the serum protein levels in horses affected with laminitis, a hoof disease. The researchers studied two separate groups of horses and ponies and found that an increasing severity of laminitis correlated with a decrease in the alpha 1-globulin protein fraction.

Methodology

• The research involved evaluating the spectrum of serum proteins in 46 horses suffering from spontaneous laminitis. The aim was to analyze the correlation between the severity of the disease and changes in the protein pattern.
• The study was conducted on two groups of animals, group A with 21 horses of various breeds like warmblood, thoroughbred, and standardbred, and group B made up of 25 ponies.
• Both groups were subdivided based on the severity of the disease using the OBEL-grade (OG) classification system. This system is used to classify laminitis based on its severity.
• The serum proteins were separated using different one and two-dimensional electrophoretic methods. Electrophoresis is a technique used to separate and identify proteins based on their size and charge.

Findings and Conclusion

• The researchers observed that the electrophoresis of sera showed significant differences in the alpha 1-globulin fraction between OG II and OG IV affected horses. This meant that as the severity of the disease increased (from OG II to OG IV), there was a corresponding decrease in the level of alpha-1 globulin protein fraction.
• In group B (the ponies), there were significant differences in the alpha 1-globulin fractions in OG II and OG III affected ponies and in the beta 2-globulin fractions in ponies affected by OG I and OG II.
• This study also included a preliminary examination of acute phase proteins C3c, C4, Hp, and fibronectin in horse serum. These proteins are known to increase in various conditions of stress, infection, or inflammation. The researchers were able to determine these proteins using antibodies against homologous human proteins, taking advantage of their cross-reactivity (their ability to react with more than one type of antigen).